Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 2Phase 3 Interventional

Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease

ClinicalTrials.gov ID: NCT05267535

Public ClinicalTrials.gov record NCT05267535. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 2:01 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Delayed Start, Double Blind, Parallel Group, Placebo Controlled, Multicenter Study of Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Randomized efficacy and safety study of piromelatine 20 mg versus placebo in participants with mild dementia due to Alzheimer's disease (AD) who are 2:107,510,000-107,540,000 polymorphism non-carriers with the primary objective to compare the effect of piromelatine to that of placebo on the AD Assessment Scale cognitive subscale (ADAS-cog14) at Week 26 of double-blind treatment.

Study identification

NCT ID
NCT05267535
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Neurim Pharmaceuticals Ltd.
Industry
Enrollment
225 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
60 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 11, 2022
Primary completion
May 31, 2025
Completion
May 31, 2025
Last update posted
Jun 20, 2024

2022 – 2025

United States locations

U.S. sites
32
U.S. states
11
U.S. cities
24
Facility City State ZIP Site status
ATP Clinical Research Costa Mesa California 92626
Collaborative Neuroscience Research, LLC Long Beach California 90806
Asclepes Research Centers, P.C. Dba Alliance Research Long Beach California 90807
Pacific Research Network, LLC San Diego California 92103
RAA Apex Acquisition LLC DBA Syrentis Clinical Research Santa Ana California 92705
The Mile High Research Center Denver Colorado 80218
Linfritz Research Institute Inc. Coral Gables Florida 33134
Finlay Medical Research Corp. Greenacres City Florida 33467
Velocity Clinical Research, Inc Hallandale Florida 33009
K2 Medical Research The Villages Lady Lake Florida 32159
Verus Clinical research Corp Miami Florida 33125
BioMed Research Institute, Inc. Miami Florida 33126
CCM Clinical Research Group, LLC Miami Florida 33133
Advance Medical Research Center Miami Florida 33135
Allied Biomedical Research Institute (Clinical Trials) Miami Florida 33135
Vitae Research Center LLC. Miami Florida 33135
Stein Gerontological Institute, Inc. Miami Florida 33137
Miami Dade Medical Research Institute Miami Florida 33176
K2 Medical Research Winter Garden Ocoee Florida 34761
Interspond, LLC, Orlando Florida 32807
The University of South Florida Board of Trustees, Tampa Florida 33613
Alzheimer's Research and Treatment Center Wellington Florida 33414
Velocity Clinical Research, Inc Meridian Idaho 83642
Ocean Medical Research Jersey City New Jersey 08755,
Advanced Memory Research Institute of New Jersey Toms River New Jersey 08755
Integrative Clinical Trials LLC Brooklyn New York 11229
New York University School of Medicine New York New York 10016
AMC Research, LLC Matthews North Carolina 28105
Rhode Island mood and memory research institute Island Park Rhode Island 02914
Neurology Clinic, P.C. Cordova Tennessee 38018
Northwest Clinical Research Center Bellevue Washington 98007
Froedtert & Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05267535, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 20, 2024 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05267535 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →